Spending Assessment and Economic Burden of COVID-19 in Mongolia,January- September,2020

Bartsch S Ferguson M McKinnell J , et al. The potential health care costs and resource use associated with COVID-19 In the United States. Health Aff (Millwood). 2020;39(6):927-935. doi:10.1377/hlthaff.2020.00426.

Jin H Wang H Li X , et al. Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study. Bull World Health Organ. 2021;99:112-124. doi:10.2471/BLT.20.267112.

Darab MG Keshavarz K Sadeghi E , et al. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran. BMC Health Serv Res. 2021;21:132. doi:10.1186/s12913-021-06126-8.

Di Fusco M Shea KM Lin J , et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308-317. doi:10.1080/13696998.2021.1886109.

González López-Valcárcel B Vallejo-Torres L . The costs of COVID-19 and the cost-effectiveness of testing. AEA. 2021;29(85):77-89. doi:10.1108/AEA-11-2020-0162.

Erkhembayar R Dickinson E Badarch D , et al. Early policy actions and emergency response to the COVID-19 pandemic in Mongolia: experiences and challenges. Lancet Glob Health. 2020;8(9):e1234-e1241. doi:10.1016/ S2214-109X(20)30295-3

United Nations Programme on HIV/AIDS. National AIDS Spending Assessment Publications and tools. https://www.unaids.org/en/dataanalysis/datatools/nasapublicationsandtools. Published 2009. Accessed August 20. 2020.